On November 21, 2017 Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, reported that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the 29th Annual Piper Jaffray Healthcare Conference, taking place November 28-29 at the Lotte New York Palace Hotel in New York City (Press release, Molecular Templates, NOV 21, 2017, View Source [SID1234522212]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Molecular Templates Presentation Details
Date: Tuesday, November 28
Time: 9:30am Eastern Time
Location: Lotte New York Palace Hotel, Track 6, Kennedy 1 Room
Webcast: View Source;tp_key=3ce376224c